Highlights on infections and SCT complications
June 12, 2023
Dr. Alexander Schauwvlieghe chaired the session on infections and SCT complications and gave a nice overview of the most interesting studies relevant for practice.
From 8 till 11 June 2023: HIGHLIGHTS ON HEMATOLOGY
Your direct line with Frankfurt
From 8 till 11 Juni 2023, The European Hematology Association (EHA) is taking place in Frankfurt, Germany. The MediMix team is onsite, and will – together with your Belgian colleagues – keep you posted about the hottest topics as they happen.
And, we also dive into posters and hot topics with both Belgian and international experts.
Stay tuned!
With the educational support of:
Daily highlights
Highlights on platelets and inflammation
June 11, 2023
Professor Kimberly Martinod from the Department of Cardiovascular Sciences at KU Leuven had the honor to give a presentation on platelets and inflammation during the closing plenary session at EHA.
Ageing and hematology: how to cope with the silver wave in hematology
June 10, 2023
Prof. em. Dominique Bron provided a comprehensive summary of the EHA Specialized Working Group on ‘Ageing and Hematology’. The group deliberated on the challenges of managing hematological conditions in octogenarians
Advances in the science and care of persons with bleeding disorders
June 10, 2023
Prof. Cathérine Lambert gives an overview of the session ‘Advances in the science and care of persons with bleeding disorders’. She discussed a cross-sectional survey evaluating the assessment of joint
CARTITUDE-4: the first phase 3 results
June 9, 2023
Prof. Michel Delforge provided a comprehensive summary of the current state of multiple myeloma treatment. He also shared the initial findings from the CARTITUDE-4 study’s phase 3 results, which compared
In the spotlight
Pieter Van Vlierberghe honoured with David Grimwade Award: Exploring novel therapeutic strategies for T-cell acute lymphoblastic leukemia
June 9, 2023
Prof Pieter Van Vlierberghe has been posthumously honoured with the renowned David Grimwade Award, in recognition of his groundbreaking work in basic and translational research. The award lecture was given by his collegue Prof. Steven Goossens from the Cancer Research Institute of Ghent University who was so kind to highlight Prof Van Vlierberghe’s pivotal research and its potential to advance treatment options for T-cell acute lymphoblastic leukemia.
In-depth stories
The therapeutic revolution for the management of multiple myeloma
June 15, 2023
Dr. Claudio Cerchione, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy, was so kind to share his insights on the therapeutic revolution for the management
The phase 1/2 Bruin study
June 14, 2023
Prof. Wojciech Jurczak discussed the data from the phase 1 / 2 Bruin study evaluating pirtobrutinib in patients with mantle cell lymphoma, pretreated with a covalent BTK-inhibitor.
In the spotlight: Jan Cools, editor-in-chief of HemaSphere
June 13, 2023
MediMix had an interview with Prof. Jan Cools from KU Leuven and editor-in-chief of HemaSphere. He looks back on his career and the start of HemaSphere and closes with his
The unmet need in patients with multiple myeloma at first relapse
June 12, 2023
Prof. Maria Victoria Mateos, hematologist at the Hospital Universitario De Salamanca, Spain discussed the unmet need in patients with multiple myeloma at first relapse and summarised subgroup data from the
BTK inhibitors as first line treatment in mantle cell lymphoma: a debate
June 11, 2023
Dr. Jeanette Doorduijn, hematologist at the Erasme hospital in Rotterdam participated in the debate on whether BTK inhibitors should be used as first line treatment in mantle cell lymphoma. She
Diagnosis and treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN)
June 10, 2023
Dr. Claudio Cerchione, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy, was so kind to give us an update on the diagnosis and treatment of
José Carreras Award: Ph+ ALL, from the worst malignancy to a chemo/transplant-free management
June 9, 2023
Dr. Tim Pieters discussed his research focusing on modelling of blood cancers in mice. He gave a summary of his presentation at EHA 2023 about the relation between SOX11 overexpression
SOX11 overexpression and mantle cell lymphomas formation
June 8, 2023
Dr. Tim Pieters discussed his research focusing on modelling of blood cancers in mice. He gave a summary of his presentation at EHA 2023 about the relation between SOX11 overexpression
Poster selection
Extracellular vesicles from chronic lymphocytic leukemia cells induce the differentiation of monocytes into nurse-like cells
June 9, 2023
What is the impact of BCR stimulation on miRNA content in CLL cells and EVs? And what is the impact of CLL-EVs on moncytes? That’s what this study aims to
A dual role for PSIP1 in T-ALL
June 9, 2023
This study identifies the role of PSOP1 in the initiation and maintenance of T-ALL, by analyzing the effects caused by PSIP1 loss, both in mice models and human T-ALL cell
Real-world insights on the management of iTTP with Caplacizumab
June 9, 2023
The aim of this project is to determine the effective concentration (EC) of TXA using the GFC/LT, to facilitate TXA use in surgery or trauma. For this, the research team
Effective concentration of TXA using the GFC/LT
June 9, 2023
The aim of this project is to determine the effective concentration (EC) of TXA using the GFC/LT, to facilitate TXA use in surgery or trauma. For this, the research team
A Novel Mammalian L-ASNase in the treatment of T-ALL
June 9, 2023
n this study, a research group from Ghent University aims to develop a less toxic an non immunogenic L-ASNase with similar L-ASNase activity as FDA-approved L-ASNase, but without the toxic